| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.OPHTHA.2013.10.027 |
| P8608 | Fatcat ID | release_qmcwb7nrtbdwdlheuz4rzwnbhy |
| P932 | PMC publication ID | 3918479 |
| P698 | PubMed publication ID | 24211172 |
| P50 | author | Emily Chew | Q24266614 |
| Susan B Bressler | Q114739669 | ||
| Judy E. Kim | Q119820197 | ||
| P2093 | author name string | Michael J Elman | |
| Jeffrey S Heier | |||
| Amitha Domalpally | |||
| Ronald P Danis | |||
| Traci E Clemons | |||
| AREDS2-HOME Study Research Group | |||
| Richard Garfinkel | |||
| P2860 | cites work | Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 |
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
| 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies | Q30944227 | ||
| Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularization in age-related macular degeneration | Q33312254 | ||
| Long-Term Monitoring of Age-Related Macular Degeneration with Preferential Hyperacuity Perimetry | Q33691973 | ||
| Editorial: Visual acuity and hyperacuity | Q34086730 | ||
| Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration | Q34437164 | ||
| Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study | Q34659554 | ||
| Longitudinal analysis of the relationship between regular eye examinations and changes in visual and functional status. | Q36307896 | ||
| The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
| Macular function surveillance revisited | Q37199464 | ||
| Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial | Q38009430 | ||
| A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol | Q44178716 | ||
| Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy. | Q45936377 | ||
| Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
| Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results | Q46940817 | ||
| Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration | Q46956320 | ||
| Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. | Q52886344 | ||
| Earliest symptoms caused by neovascular membranes in the macula | Q68957139 | ||
| Time to first treatment: The significance of early treatment of exudative age-related macular degeneration | Q83079783 | ||
| Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: multicenter evaluation of a preferential hyperacuity perimeter designed as a home device | Q83196831 | ||
| Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab | Q84874587 | ||
| P433 | issue | 2 | |
| P921 | main subject | neovascularization | Q1281049 |
| P304 | page(s) | 535-544 | |
| P577 | publication date | 2013-11-08 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study | |
| P478 | volume | 121 |
| Q91966925 | A Novel Method for Detection and Progress Assessment of Visual Distortion Caused by Macular Disorder: A Central Serous Chorioretinopathy (CSR) Case Study |
| Q52606074 | Accuracy of a Self-monitoring Test for Identification and Monitoring of Age-related Macular Degeneration: A Diagnostic Case-control Study. |
| Q42565175 | Advances in technology helps in early detection of vision disorders |
| Q26799617 | Age-Related Macular Degeneration: Advances in Management and Diagnosis |
| Q26777085 | An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review |
| Q38979931 | Assessment of visual distortions in age-related macular degeneration: emergence of new approaches |
| Q96431649 | Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade |
| Q89593937 | CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus |
| Q35118257 | Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. |
| Q96172012 | Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group |
| Q33891126 | Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis |
| Q99212624 | Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective |
| Q30847473 | Does Testing More Frequently Shorten the Time to Detect Disease Progression? |
| Q42132292 | EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3 |
| Q38867052 | Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System |
| Q47355167 | Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degeneration. |
| Q34092454 | Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). |
| Q98563377 | Home Monitoring of Age-Related Macular Degeneration: Real-World Utility of the ForeseeHome Device for Detection of Neovascularization |
| Q58599946 | Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration |
| Q94671854 | Home monitoring as a useful extension of modern tele-ophthalmology |
| Q99568053 | Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak |
| Q104795272 | Identifying early symptoms of choroidal neovascularisation in second eyes of patients with unilateral wet age related macular degeneration using a telephone evaluation method |
| Q39042323 | Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial |
| Q26824335 | Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development |
| Q101476469 | Optical coherence tomography in the 2020s-outside the eye clinic |
| Q88816244 | Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration |
| Q90626152 | Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition |
| Q99239361 | Predicting risk of late age-related macular degeneration using deep learning |
| Q58588071 | Radial shape discrimination testing for new-onset neovascular age-related macular degeneration in at-risk eyes |
| Q39307436 | Reaching the Unreachable: Novel Approaches to Telemedicine Screening of Underserved Populations for Vitreoretinal Disease |
| Q41532061 | Recent developments in age-related macular degeneration: a review. |
| Q91676618 | Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration |
| Q98165580 | Remote screening of retinal and optic disc diseases using handheld nonmydriatic cameras in programmed routine occupational health checkups onsite at work centers |
| Q90539652 | Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring |
| Q33444081 | Self-Testing of Vision in Age-Related Macula Degeneration: A Longitudinal Pilot Study Using a Smartphone-Based Rarebit Test. |
| Q38367104 | Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration. |
| Q38637031 | Tele-ophthalmology for Age-Related Macular Degeneration and Diabetic Retinopathy Screening: A Systematic Review and Meta-analysis. |
| Q90626155 | Telemedicine for Age-Related Macular Degeneration |
| Q35841740 | The Chronic Care for Wet Age Related Macular Degeneration (CHARMED) Study: A Randomized Controlled Trial |
| Q35716443 | The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study |
| Q38667170 | The Current State of Teleophthalmology in the United States. |
| Q52838532 | The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD. |
| Q90197758 | The impact of artificial intelligence in the diagnosis and management of glaucoma |
| Q34674568 | The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration |
| Q36028992 | UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12 |
| Q42406207 | Validation of a Tablet as a Tangent Perimeter |
Search more.